This episode currently has no reviews.
Submit ReviewIs there more trouble brewing in the office real estate space? The shocking stat that could mean big problems for lenders, and why the government may need to get involved. Plus Insmed’s incredible day. The pharma stock surging as new drug trial results blow past expectations. What it could mean for the future of the company.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review